There is increasing evidence that the clinical presentation of insulin dependent, type 1 diabetes in several low- and middle-income countries (LMIC) is different from the ‘classical’ presentation in affluent countries; this is particularly the case in sub-Saharan Africa (SSA). Here, INS is linked to type 1 diabetes mellitus.